Show me india style trt priscription
"Testosterone"[MeSH Terms] AND "Hypogonadism"[MeSH Terms]
India testosterone replacement therapy prescription testosterone enanthate hypogonadism guidelines
PRESCRIPTION / Rx
Dr. _______________________________ Date: ____ / ____ / ______
Qualification: _____________________ Reg. No.: __________________
Clinic/Hospital: _____________________________________________________
Patient name: ______________________ Age/Sex: ______ / M
Address: _____________________________________________________________
Weight: ______ kg Allergies: ______________________________________
Diagnosis:
□ Confirmed male hypogonadism
□ Primary / secondary / under evaluation
Relevant reports reviewed:
□ 2 separate early-morning total testosterone results
□ LH, FSH, prolactin □ CBC/hematocrit
□ PSA and prostate assessment where clinically appropriate
□ LFT, lipid profile, glucose/HbA1c as indicated
Rx
1. Testosterone formulation: _________________________________________
Strength/form: ____________________________________________________
Route: ____________________________________________________________
Directions: Use only as specifically explained by the prescriber.
Quantity: ______________________
2. [Other medicine only if clinically indicated]
___________________________________________________________________
Directions: _______________________________________________________
Advice:
- Do not self-inject, share, or alter the dose/interval.
- Report acne, breast tenderness, leg swelling, breathlessness,
mood changes, severe headache, urinary symptoms, or sleep-apnoea
worsening.
- Testosterone can suppress sperm production. Discuss fertility before
starting treatment.
- Follow-up with CBC/hematocrit, testosterone level, symptom review and
prostate monitoring where relevant, as advised.
Review after: ______________________
Doctor’s signature and stamp
____________________________________
Pls genrate a trt prescription
"Testosterone"[MeSH Terms] AND "Hypogonadism"[MeSH Terms]
testosterone therapy diagnosis confirm repeat morning testosterone guideline
Genrate trt template
TESTOSTERONE THERAPY (TRT) REVIEW
Clinic/Hospital: _________________________________________________
Consulting doctor: _______________________________________________
Speciality: □ Endocrinology □ Urology □ Andrology
Date: ____ / ____ / ______
PATIENT DETAILS
Name: ____________________________________________________________
Age: ______ years Sex: ______ UHID/OPD No.: __________
Phone: ___________________________________________________________
Known allergies: __________________________________________________
CLINICAL INDICATION
Symptoms present:
□ Low libido □ Erectile dysfunction □ Fatigue
□ Reduced morning erections □ Low mood □ Reduced muscle mass
□ Low bone density/fracture □ Other: ___________________________
Duration of symptoms: ____________________________________________
Past medical/surgical history: ____________________________________
Current medicines/supplements: ____________________________________
Fertility plans now or in future: □ Yes □ No □ Unsure
DIAGNOSTIC ASSESSMENT
Two early-morning fasting total testosterone values:
1. Date: __________ Result: __________ Unit: _________________
2. Date: __________ Result: __________ Unit: _________________
Supporting investigations:
□ LH / FSH □ Prolactin □ SHBG/free testosterone
□ CBC and hematocrit □ PSA, if appropriate
□ Liver function □ Lipid profile □ HbA1c/glucose
□ Blood pressure □ Sleep-apnoea screening
□ Other: ________________________________________________________
ASSESSMENT
□ Confirmed hypogonadism
□ Primary hypogonadism
□ Secondary hypogonadism
□ Functional/reversible cause being addressed
□ Further evaluation needed before considering TRT
SAFETY SCREEN
□ Fertility counselling completed
□ No known prostate/breast malignancy
□ Hematocrit reviewed
□ PSA/prostate assessment reviewed when clinically appropriate
□ Cardiovascular history reviewed
□ Sleep apnoea reviewed
□ Contraindications/precautions discussed
CLINICIAN-SELECTED TREATMENT PLAN
Testosterone product/formulation: __________________________________
Strength and route: ________________________________________________
Dose and schedule: ________________________________________________
Duration / review date: ____________________________________________
MONITORING PLAN
□ Clinical symptom response
□ Testosterone level
□ CBC / hematocrit
□ PSA/prostate review where indicated
□ Blood pressure, metabolic and adverse-effect review
Next review date: ____ / ____ / ______
COUNSELLING DOCUMENTED
□ Do not self-adjust or share medication
□ May reduce sperm production and affect fertility
□ Possible acne, oily skin, mood changes, breast tenderness
□ Report leg swelling, breathing difficulty, severe headache,
urinary symptoms, or worsening sleep apnoea promptly
Clinician notes:
__________________________________________________________________
__________________________________________________________________